| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |